Predict your next investment

HEALTHCARE | Drug Manufacturing / Vitamins, Supplements & Nutraceuticals
twinlab.com

See what CB Insights has to offer

Stage

Reverse Merger | IPO

Total Raised

$187M

About Twinlab Consolidated Corporation

Twinlab Consolidation Corporation is an industry-focused health and wellness company committed to developing top brands. An employee-owned company, TCC aligns the interest of all stakeholders and has a portfolio of products that are made in America using the finest ingredients from around the world. In addition to its namesake brand, Twinlab, established in 1968, TCC also manufactures and sells other well-known category leaders including the Metabolife line of diet and energy products; Fuel line of sports supplement products; Alvita teas, established in 1922 as a single-herb tea line; Trigosamine joint support products as well other health and wellness brands. Twinlab's manufacturing facility in American Fork, Utah is an NSF GMP and NSF GMP for Sport certified facility. Visit www.twinlab.com for more information.

Twinlab Consolidated Corporation Headquarter Location

632 Broadway

New York, New York, 10012,

United States

212-651-8500

Latest Twinlab Consolidated Corporation News

L-Histidine Market 2021: Current Trends And Future Aspect Analysis 2028 | Top Companies-Merck & Co., Inc., Twinlab Consolidated Corporation., Hoffmann-La Roche Ltd, Amgen Inc

Jan 12, 2021

| Top Companies-Merck & Co., Inc., Twinlab Consolidated Corporation., Hoffmann-La Roche Ltd, Amgen Inc DBMR has added a new report titled Global L-Histidine Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The report forecasts the innovative applications of Global L-Histidine Market on the basis of these estimations. This market research analysis report starts with a basic introduction of the 2019 market segmentation, future scenario, industry growth rate, and industrial opportunities to 2028. Company profile comprises parameters such as company synopsis, commercial synopsis, work strategy and planning, SWOT analysis and present developments. The report gives out an outlook of the business chain structure and explains the industry environment, then analyzes the market size and forecast by product, region and market application. Global L-Histidine Market research report helps in growing sales with new thinking, new skills, and innovative programs and tools. With the study of competitor analysis, industry can get know-how of the strategies of key players in the market that includes but are not limited to new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions. The report will act as a sure shot solution to the challenges and problems faced by industry. A comprehensive data and information provided in the report can be utilized by industry to be acquainted with the present and upcoming opportunities and clarify the future investment in the market. Global L-histidine market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.90% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market. Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-l-histidine-market The major players covered in the market are Angene International Limited, Novartis AG, Merck & Co., Inc., Twinlab Consolidated Corporation., Hoffmann-La Roche Ltd, Amgen Inc., ABI Chem Germany, Acron Laboratories PVT LTD, Eisai Co., Ltd., GlaxoSmithKline plc., Pfizer, Inc., CHANGZHOU HIGHASSAY CHEMICAL CO., LTD and Nordisk A/S among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Competitive Landscape and Global L-Histidine Market Share Analysis L-histidine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to L-histidine market. The molecular weight of L-histidine is 155.15 g/mol. It functions as a nutraceutical, micronutrient, human metabolite, and E.coli metabolite. It’s a proteinogenic amino acid that helps in the growth and repairing of body tissues, protects the myelin sheaths, improves immunity, improves gastric function, and improves sexual functions. However, technological advancement in treatment and diagnosis of chronic diseases and rising incidence of autoimmune disorders and chronic diseases such as rare disorders, cancers, and diabetes also boost up the market growth. Moreover, increasing demand for cost-efficient therapeutics in developing regions and an increase in the approval of new drugs for the treatment of chronic diseases act as an opportunity for market growth. However, the long process for manufacturing and stringent rules & regulations about facilities and equipment required for L-histidine drug may hamper the global L-histidine drug. This L-histidine market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief ,  our team will help you create a revenue impact solution to achieve your desired goal. For More Insights Get FREE Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-l-histidine-market Global L-Histidine Market Scope and Market Size The L-histidine market is segmented on the basis of applications, product, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of applications, the L-histidine market is segmented rheumatoid arthritis, allergy, anemia, ulcers, and others. On the basis of product, the L-histidine market is segmented into capsules, intravebous, tablets, and others. On the basis of end-users, the L-histidine market is segmented into hospitals, specialty clinics, ambulatory surgical centres and others. On the basis of distribution channel, the L-histidine market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. L-Histidine Market Country Level Analysis L-histidine market is analysed and market size information is provided by country, applications, product, end-users and distribution channel as referenced above. The countries covered in the L-histidine market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa. On geographical estimation, North America accounts for the largest market share due to the presence of high healthcare expenditure and favorable reimbursement policies for the treatment. Europe accounts for the second-largest market share due to increased genetic disorders and the presence of refined medical facilities. Asia-Pacific is expected to account for the largest market share over the coming years for the L-histidine drug due to the constant rise in the incidence of cancer coupled with increased demand for cost-efficient therapeutics. The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT– GET FREE COVID-19 SAMPLE@ https://www.databridgemarketresearch.com/covid-19-impact/global-l-histidine-market Patient Epidemiology Analysis L-histidine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period. About Data Bridge Market Research: An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Twinlab Consolidated Corporation

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Twinlab Consolidated Corporation is included in 1 Expert Collection, including Vitamin & Supplement Startups.

V

Vitamin & Supplement Startups

628 items

Twinlab Consolidated Corporation Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Twinlab Consolidated Corporation Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.